Albireo Pharma, Inc. (NASDAQ: ALBO) today announced that subsidiary Elobix AB has entered into an agreement with HealthCare Royalty Partners ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE